Add to Basket
Order hotline:
![]() |
+1 404 474 4654 |
![]() |
+1 888 205 9894 (TF) |
Keratin 20 (KRT20) antibody
| Antigen | Keratin 20 (KRT20) |
| Synonyms | K20, CD20, CK20, KRT21, MGC35423, 9030623C06Rik, Krt21, KRT20, MGC152269 |
| Clonality | Monoclonal (KS20-5) |
| Host |
Alternatives Mouse |
| Reactivity |
Alternatives Human, Pig (Porcine) |
| Conjugate |
Alternatives Un-conjugated |
| Application |
Alternatives Immunohistochemistry (Frozen Sections) (IHC (fro)), Western Blotting (WB) |
![]() |
7 references available |
| Catalog no. | ABIN125990 |
| Quantity | 50 µg |
| Price | 528.00 $ Plus shipping costs $45.00 |
| Shipping to |
|
| Availability | Will be delivered in 6 to 8 Business Days |
Additional Information
| Alternative name | Cytokeratin 20 |
| UniProt | P35900 |
| Immunogen | Electrophoretically purified keratin K20 from human intestinal mucosa. |
| Cross-Reactivity | Human, Pig (Porcine) |
| Isotype | IgG2a |
| Clone | KS20-5 |
| Description | Cytokeratin 20 is a type I keratin which is primarily expressed in gastric and intestinalepithelium, urothelium, and Merkel-cells. The keratins are intermediate filament proteinsresponsible for the structural integrity of epithelial cells and are subdivided intocytokeratins and hair keratins. The type I cytokeratins consist of acidic proteins which arearranged in pairs of heterotypic keratin chains. Their genes are clustered in a region ofchromosome 17q12-q21. Cytokeratin 20 is a major cellular protein of mature enterocytesand goblet cells and is specifically expressed in the gastric and intestinal mucosa. It isalso expressed in adenocarcinomas of the colon, stomach, pancreas and the bile systemand is present in mucinous ovarian tumors, transitional-cell and Merkel-cell carcinomas. Notably, the squamous cell carcinomas and adenocarcinomas of the breast, lung, andendometrium, non-mucinous tumors of the ovary, and small cell carcinomas lackcytokeratin 20. |
| Characteristics | Synonyms: Cytokeratin 20, Keratin-20, KRT20, CK20, K20, Protein IT, Keratin type I cytoskeletal 20 |
Application Details
| Application Notes | Immunohistochemical on frozen sections: 1: 10, 1h at RT or over night at 2-8C. Immunohistochemical on cytological material. Immunoblotting. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user. |
| Purification | Purified |
| Buffer | PBS buffer, pH 7.4 containing 0.09 % sodium azide, 0.5% BSAReconstitution: Restore in 1 ml dist. water |
| Storage | Prior to reconstitution store at 2-8°C. Following reconstitution store the antibody at -20°C. Avoid repeated freezing and thawing. Shelf life: one year from despatch. |
| Research Area | Signaling, Cytoskeleton, Cytokeratins, Extracellular Matrix, Cancer |
| Restrictions | For Research Use only |
Publications
|
Moll, Loewe, Laufer et al.: "Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies." in: The American journal of pathology, Vol. 140, Issue 2, pp. 427-47, 1992 (PubMed).
Moll, Schiller, Franke: "Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns." in: The Journal of cell biology, Vol. 111, Issue 2, pp. 567-80, 1990 (PubMed). Moll, Moll: "Comparative cytokeratin analysis of sweat gland ducts and eccrine poromas." in: Archives of dermatological research, Vol. 283, Issue 5, pp. 300-9, 1991 (PubMed). Moebus, Moll, Gerharz et al.: "Establishment of new ovarian and colon carcinoma cell lines: differentiation is only possible by cytokeratin analysis." in: British journal of cancer, Vol. 69, Issue 3, pp. 422-8, 1994 (PubMed). Moll, Zimbelmann, Goldschmidt et al.: "The human gene encoding cytokeratin 20 and its expression during fetal development and in gastrointestinal carcinomas." in: Differentiation; research in biological diversity, Vol. 53, Issue 2, pp. 75-93, 1993 (PubMed). Demirkesen, Hoede, Moll: "Epithelial markers and differentiation in adnexal neoplasms of the skin: an immunohistochemical study including individual cytokeratins." in: Journal of cutaneous pathology, Vol. 22, Issue 6, pp. 518-35, 1996 (PubMed). Harnden, Eardley, Joyce et al.: "Cytokeratin 20 as an objective marker of urothelial dysplasia." in: British journal of urology, Vol. 78, Issue 6, pp. 870-5, 1997 (PubMed). |
|
Alternatives
Alternatives for antigen "Keratin 20 (KRT20)", type "Antibodies"
| Hosts | Mouse (58), Rabbit (51), Guinea Pig (2) |
| Reactivities | Human (102), Rat (Rattus) (33), Mouse (Murine) (30), Pig (Porcine) (3), Dog (Canine) (2), Cat (Feline) (1), Chicken (1), Cow (Bovine) (1) |
| Applications | Western Blotting (WB) (68), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)) (61), Immunohistochemistry (IHC) (25), ELISA (23), Immunofluorescence (IF) (22), Immunohistochemistry (Frozen Sections) (IHC (fro)) (10), Immunoprecipitation (IP) (10), Immunohistochemistry (Fixed) (IHC (fx)) (7), Immunocytochemistry (ICC) (5), Immunohistochemistry (Formalin-fixed Sections) (IHC (f)) (5), Flow Cytometry (FACS) (2), Dot Blot (DB) (1), Immunoelectron Microscopy (IEM) (1) |
| Conjugates | FITC (4), Biotin (3), HRP (2), Alexa Fluor 350 (1), Alexa Fluor 488 (1), Alexa Fluor 555 (1), Alexa Fluor 647 (1), Cy3 (1), Cy5 (1), Cy5.5 (1), Cy7 (1), Gold (1), PE (1), PE,Cy3 (1), PE,Cy5 (1), PE,Cy5.5 (1), PE,Cy7 (1) |
| Epitopes | C-Term (2), Internal Region (1) |




Alternatives